Investor Type | Firm |
Industries | BioTech • Oncology |
Investing | United States |
Investment Range | $20,010,000 - $20,010,000 |
NLabs operates as a family office venture capital firm, with a clear focus on investing in technology. The firm, which was initially spun out of Navation Inc. in 2013, has a storied background dating back to Navation Inc.'s formation in 1989. NLabs' investment strategy revolves around identifying and nurturing companies that have the potential to fundamentally alter the manner in which we lead our lives. To achieve this, NLabs targets sectors such as media, communications, computing, and biotechnology, particularly with a strong emphasis on BioTech and Oncology industries. Through a comprehensive approach to investments, the firm plays a pivotal role in empowering companies to attain their financial goals and scale effectively. With a minimum and maximum investment limit of $20,010,000, NLabs positions itself as a substantial contributor in financing rounds, committed to making significant stakes in high-potential ventures. Founded by Allen Salmasi, NLabs takes pride in its seasoned investment team that collectively boasts over 60 years of industry expertise. This experience is complemented by a vast and robust network encompassing entrepreneurs, consultants, researchers, academics, lawyers, and others who contribute their specialized knowledge to NLabs' investment process. NLabs maintains a global influence with a diverse portfolio that spans early-stage enterprises to publicly traded companies, achieving worldwide impact and fostering innovation on a global scale. The company's partnering strategy includes collaboration with other investors, established companies, start-up entities, innovators, research labs, and universities. This ecosystem of partnerships is central to NLabs' philosophy of facilitating breakthrough developments and driving growth. The firm adheres to a strict policy ensuring that any information presented on their website should not be misconstrued as an offer to sell or a solicitation of an offer to purchase any securities or investments, as this is not intended for the general public.